Potential and Pitfalls of SGLT2 Inhibitors in the Management of Equine Metabolic Syndrome
Dr. David Rendle discusses the use of SGLT2 inhibitors in the management of equine metabolic syndrome. After watching the webinar, you’ll feel confident in knowing when to consider and when to stop treatment with SGLT2 inhibitors.
Due to the severe winter storm and inclement weather affecting the Northeast, shipments will experience delays. We appreciate your patience and understanding as carriers work to ensure deliveries are completed safely.